Silk Road Medical, Inc

NasdaqGS:SILK Stock Report

Market Cap: US$733.0m

Silk Road Medical Past Earnings Performance

Past criteria checks 0/6

Silk Road Medical's earnings have been declining at an average annual rate of -3.5%, while the Medical Equipment industry saw earnings growing at 13.5% annually. Revenues have been growing at an average rate of 28% per year.

Key information

-3.5%

Earnings growth rate

76.6%

EPS growth rate

Medical Equipment Industry Growth8.9%
Revenue growth rate28.0%
Return on equity-36.9%
Net Margin-31.5%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

Silk Road Medical, Inc's (NASDAQ:SILK) Shares Leap 35% Yet They're Still Not Telling The Full Story

Feb 03
Silk Road Medical, Inc's (NASDAQ:SILK) Shares Leap 35% Yet They're Still Not Telling The Full Story

A Piece Of The Puzzle Missing From Silk Road Medical, Inc's (NASDAQ:SILK) 26% Share Price Climb

Dec 20
A Piece Of The Puzzle Missing From Silk Road Medical, Inc's (NASDAQ:SILK) 26% Share Price Climb

Is Silk Road Medical (NASDAQ:SILK) Weighed On By Its Debt Load?

Nov 03
Is Silk Road Medical (NASDAQ:SILK) Weighed On By Its Debt Load?

Is Silk Road Medical (NASDAQ:SILK) A Risky Investment?

Aug 05
Is Silk Road Medical (NASDAQ:SILK) A Risky Investment?

Shareholders Should Be Pleased With Silk Road Medical, Inc's (NASDAQ:SILK) Price

May 05
Shareholders Should Be Pleased With Silk Road Medical, Inc's (NASDAQ:SILK) Price

Is Silk Road Medical (NASDAQ:SILK) A Risky Investment?

Apr 04
Is Silk Road Medical (NASDAQ:SILK) A Risky Investment?

Silk Road Medical announces $100M common stock offering

Oct 17

Is Silk Road Medical (NASDAQ:SILK) Using Too Much Debt?

Sep 24
Is Silk Road Medical (NASDAQ:SILK) Using Too Much Debt?

Silk Road Medical GAAP EPS of -$0.44 beats by $0.02, revenue of $33.17M beats by $2.14M

Jul 26

Silk Road Medical: Divergence From Alternative Risk Premia Means Lack Of Upside Capture

Jul 19

Silk Road Medical falls after Citigroup downgrades to Sell from Neutral

Jul 11

Is Silk Road Medical (NASDAQ:SILK) Using Too Much Debt?

Jun 09
Is Silk Road Medical (NASDAQ:SILK) Using Too Much Debt?

Silk Road Medical - What A Road It Has Been

Apr 08

Is Silk Road Medical (NASDAQ:SILK) Using Debt Sensibly?

Feb 23
Is Silk Road Medical (NASDAQ:SILK) Using Debt Sensibly?

Silk Road Medical, Inc's (NASDAQ:SILK) Intrinsic Value Is Potentially 48% Above Its Share Price

Jan 24
Silk Road Medical, Inc's (NASDAQ:SILK) Intrinsic Value Is Potentially 48% Above Its Share Price

Is It Too Late To Consider Buying Silk Road Medical, Inc (NASDAQ:SILK)?

Dec 09
Is It Too Late To Consider Buying Silk Road Medical, Inc (NASDAQ:SILK)?

Is Silk Road Medical (NASDAQ:SILK) Weighed On By Its Debt Load?

Nov 18
Is Silk Road Medical (NASDAQ:SILK) Weighed On By Its Debt Load?

Revenue & Expenses Breakdown
Beta

How Silk Road Medical makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NasdaqGS:SILK Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 23177-5614541
30 Sep 23170-5513840
30 Jun 23163-5313139
31 Mar 23151-5512339
31 Dec 22139-5511636
30 Sep 22127-5711135
30 Jun 22114-6110833
31 Mar 22107-5610230
31 Dec 21101-509627
30 Sep 2194-529030
30 Jun 2190-488427
31 Mar 2178-487724
31 Dec 2075-477621
30 Sep 2073-397314
30 Jun 2070-377113
31 Mar 2070-386913
31 Dec 1963-526312
30 Sep 1956-605712
30 Jun 1949-614912
31 Mar 1942-564211
31 Dec 1835-383510
31 Dec 1714-19207

Quality Earnings: SILK is currently unprofitable.

Growing Profit Margin: SILK is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: SILK is unprofitable, and losses have increased over the past 5 years at a rate of 3.5% per year.

Accelerating Growth: Unable to compare SILK's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: SILK is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (8.7%).


Return on Equity

High ROE: SILK has a negative Return on Equity (-36.88%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.